tiprankstipranks
C'BON COSMETICS Co., Ltd. (JP:4926)
:4926
Japanese Market

C'BON COSMETICS Co., Ltd. (4926) AI Stock Analysis

0 Followers

Top Page

JP:4926

C'BON COSMETICS Co., Ltd.

(4926)

Select Model
Select Model
Select Model
Neutral 58 (OpenAI - 5.2)
Rating:58Neutral
Price Target:
¥1,404.00
▲(18.18% Upside)
Action:ReiteratedDate:12/30/25
The score is driven primarily by solid financial stability from a debt-free balance sheet, offset by weak cash flow (negative operating and deeply negative free cash flow). Technicals are neutral-to-mixed, while valuation is reasonable with a moderate dividend yield and mid-range P/E.
Positive Factors
Balance sheet strength
A zero-debt balance sheet and sizable equity cushion materially reduce refinancing and solvency risk, giving management flexibility to invest in stores, product development or weather demand shocks. This conservative capital structure supports durable financial stability over months.
Negative Factors
Weak cash generation
Negative operating and sharply negative free cash flow highlight poor cash conversion and ongoing funding needs, raising execution risk. Persistent negative FCF constrains reinvestment, dividends and increases reliance on external financing despite low leverage.
Read all positive and negative factors
Positive Factors
Negative Factors
Balance sheet strength
A zero-debt balance sheet and sizable equity cushion materially reduce refinancing and solvency risk, giving management flexibility to invest in stores, product development or weather demand shocks. This conservative capital structure supports durable financial stability over months.
Read all positive factors

C'BON COSMETICS Co., Ltd. (4926) vs. iShares MSCI Japan ETF (EWJ)

C'BON COSMETICS Co., Ltd. Business Overview & Revenue Model

Company Description
C'BON COSMETICS Co.,Ltd. manufactures and sells cosmetics, quasi-drugs, and beauty appliance products. It offers various products, such as cleansing, lotion, cream, face wash, serum, and makeup base products. The company was founded in 1966 and is...
How the Company Makes Money
C'BON COSMETICS primarily generates revenue by selling its cosmetics and skincare products to customers, with sales supported by in-person counseling and recurring customer relationships. A second core revenue stream comes from beauty services (e....

C'BON COSMETICS Co., Ltd. Financial Statement Overview

Summary
Balance sheet strength is a key positive (no debt and solid equity cushion), but operating quality is mixed: profitability rebounded in 2025 to positive net and operating income with thin margins, while cash generation is a major weakness with negative operating cash flow and sharply negative free cash flow in 2025.
Income Statement
56
Neutral
Balance Sheet
86
Very Positive
Cash Flow
34
Negative
BreakdownTTMMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue9.02B8.84B8.50B8.53B9.15B9.10B
Gross Profit6.91B6.74B6.40B6.34B7.10B6.92B
EBITDA455.40M324.45M171.85M126.39M418.05M-679.98M
Net Income252.21M136.27M-26.35M-421.77M44.87M-621.87M
Balance Sheet
Total Assets8.67B8.60B8.81B8.84B9.56B9.56B
Cash, Cash Equivalents and Short-Term Investments2.54B2.65B3.63B3.98B2.80B2.32B
Total Debt0.000.004.24M13.27M22.30M25.20M
Total Liabilities3.00B2.89B3.15B3.13B3.36B1.97B
Stockholders Equity5.67B5.70B5.66B5.71B6.20B7.60B
Cash Flow
Free Cash Flow0.00-926.52M-301.11M-693.60M330.15M-803.08M
Operating Cash Flow0.00-43.16M278.19M-81.47M433.37M-694.00M
Investing Cash Flow0.00-849.16M-581.94M1.35B44.91M161.38M
Financing Cash Flow0.00-90.22M-31.20M-91.29M-6.73M-6.80M

C'BON COSMETICS Co., Ltd. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price1188.00
Price Trends
50DMA
1300.95
Negative
100DMA
1251.71
Positive
200DMA
1208.31
Positive
Market Momentum
MACD
-14.57
Positive
RSI
34.73
Neutral
STOCH
49.87
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4926, the sentiment is Negative. The current price of 1188 is below the 20-day moving average (MA) of 1292.95, below the 50-day MA of 1300.95, and below the 200-day MA of 1208.31, indicating a neutral trend. The MACD of -14.57 indicates Positive momentum. The RSI at 34.73 is Neutral, neither overbought nor oversold. The STOCH value of 49.87 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:4926.

C'BON COSMETICS Co., Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
69
Neutral
¥6.52B12.522.38%-0.79%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
58
Neutral
¥5.39B-33.121.68%8.46%
58
Neutral
¥8.39B-49.922.65%11.87%-31.02%
56
Neutral
¥6.11B8.181.59%-9.99%-35.06%
52
Neutral
¥5.21B42.42-19.42%
51
Neutral
¥1.93B-3.0412.96%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:4926
C'BON COSMETICS Co., Ltd.
1,260.00
172.25
15.84%
JP:4918
Ivy Cosmetics Corporation
340.00
84.38
33.01%
JP:4925
HABA Laboratories, Inc.
1,723.00
75.44
4.58%
JP:4929
ADJUVANT HOLDINGS CO., LTD.
760.00
-10.53
-1.37%
JP:4934
Premier Anti-Aging Co., Ltd.
597.00
-192.00
-24.33%
JP:4936
AXXZIA, Inc.
348.00
-42.84
-10.96%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 30, 2025